Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Recipient : Viatris
Deal Size : Inapplicable
Deal Type : Inapplicable
Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 26, 2017
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Recipient : Viatris
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pimecrolimus
Therapeutic Area : Dermatology
Study Phase : Phase III
Recipient : Viatris
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 11, 2017
Lead Product(s) : Pimecrolimus
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Recipient : Viatris
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Azelaic Acid
Therapeutic Area : Dermatology
Study Phase : Phase III
Recipient : Padagis
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 15, 2016
Lead Product(s) : Azelaic Acid
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Recipient : Padagis
Deal Size : Inapplicable
Deal Type : Inapplicable